Pharmacokinetic and Pharmacodynamic Study of CD 2027 3µg/g Oily Spray Applied Twice Daily for 3 Weeks Under Conditions of Maximized Use in Adults With Plaque-type Psoriasis
Sponsor study identifier
interventional
26
1 country
3
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Study Completion
February 2009
Actual (reported)This is a multicenter, open-label study to assess systemic plasma levels of calcitriol, calcium homeostasis and safety in adults with plaque-type psoriasis under conditions of maximized use of CD 2027 3µg/g oily spray twice daily (6 g daily), applied to 20% of BSA for 3 weeks. There are a total of six visits: Pre-treatment period (Day -15, Day -8 and Day -1) and Treatment period (Day 1/ Baseline, Day 15 and Day 22).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2009
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
September 29, 2008
Actual (reported)October 1, 2008
Actual (reported)December 2008
Actual (reported)February 2009
Actual (reported)CD 2027 plasma concentrations
0, 1, 2, 3, 4, 6, 9, 12 hour time points
Calcium homeostasis
Screening, Day -8, -1 and prior to the morning application on Day 1, 15 and 22
Burke Pharmaceutical Research
Hot Springs, Arizona, 71913, United States
DermResearch
Austin, Texas, 78759, United States
J & S Studies
Bryan, Texas, 77845, United States
26 participants (actual enrollment reported by the registry).
First Submitted
September 29, 2008
First Posted
October 1, 2008
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Contact the study team to confirm eligibility.
Primary Completion
December 2008
Actual (reported)Study Completion
February 2009
Actual (reported)Last Updated
February 18, 2021
Record last verified: 2012-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: